EVALUATION OF OPTIMAL DURATION OF CHEMOTHERAPY IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - A SOUTHEASTERN-CANCER-STUDY-GROUP PROTOCOL

被引：310

作者：

EINHORN, LH

WILLIAMS, SD

LOEHRER, PJ

BIRCH, R

DRASGA, R

OMURA, G

GRECO, FA

机构：

[1] INDIANA UNIV,DEPT MED,INDIANAPOLIS,IN 46204

[2] SE CANC STUDY GRP,CTR STAT,BIRMINGHAM,AL

[3] SE CANC STUDY GRP,CTR STAT,MERRILLVILLE,IN

[4] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL

[5] VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240

来源：

关键词：

D O I：

10.1200/JCO.1989.7.3.387

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：387 / 391

页数：5

共 13 条

[1] COMPARISON OF CRITERIA FOR ASSIGNING GERM-CELL TUMOR PATIENTS TO GOOD RISK AND POOR RISK STUDIES
BAJORIN, D
KATZ, A
CHAN, E
GELLER, N
VOGELZANG, N
BOSL, GJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) : 786 - 792
[2] PROGNOSTIC FACTORS FOR FAVORABLE OUTCOME IN DISSEMINATED GERM-CELL TUMORS
BIRCH, R
WILLIAMS, S
CONE, A
EINHORN, L
ROARK, P
TURNER, S
GRECO, FA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) : 400 - 407
[3] BOSL GJ, 1983, CANCER RES, V43, P3403
[4] CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER
EINHORN, LH
DONOHUE, J
[J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) : 293 - 298
[5] EINHORN LH, 1981, CANCER RES, V41, P3275
[6] THE ROLE OF MAINTENANCE THERAPY IN DISSEMINATED TESTICULAR CANCER
EINHORN, LH
WILLIAMS, SD
TRONER, M
BIRCH, R
GRECO, FA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (13) : 727 - 731
[7] VP-16 PLUS IFOSFAMIDE PLUS CISPLATIN AS SALVAGE THERAPY IN REFRACTORY GERM-CELL CANCER
LOEHRER, PJ
EINHORN, LH
WILLIAMS, SD
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) : 528 - 536
[8] MAKUCH R, 1978, CANCER TREAT REP, V62, P1037
[9] NICHOLS C, 1988, P AN M AM SOC CLIN, V7, P118
[10] OZOLS RF, 1983, CANCER, V51, P1803, DOI 10.1002/1097-0142(19830515)51:10<1803::AID-CNCR2820511008>3.0.CO